{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:00:45Z","timestamp":1780725645122,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.taap.2025.117585","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:12:28Z","timestamp":1759162348000},"page":"117585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modulation of NF-\u043aB\/NLRP3 signaling by sitagliptin attenuates cholestatic hepatic fibrosis"],"prefix":"10.1016","volume":"505","author":[{"given":"Marwa A.","family":"Elkosayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda E.","family":"Kafl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirhan N.","family":"Makled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina S.","family":"El-Agamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.taap.2025.117585_bb0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2014.5994","article-title":"Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?","volume":"22","author":"Abais","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174295","article-title":"Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity","volume":"12","author":"Abo-Haded","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.taap.2025.117585_bb0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/jphp.12534","article-title":"Alleviation of renal mitochondrial dysfunction and apoptosis underlies the protective effect of sitagliptin in gentamicin-induced nephrotoxicity","volume":"68","author":"Abuelezz","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4103\/AZMJ.AZMJ_161_20","article-title":"Hepatoprotective effect of dipeptidyl peptidase-4 inhibitor sitagliptin against carbon tetrachloride-induced liver fibrosis in mice","volume":"19","author":"Ahmed","year":"2021","journal-title":"Al-Azhar Assiut Medical Journal."},{"key":"10.1016\/j.taap.2025.117585_bb0025","first-page":"1","article-title":"Vincamine alleviates intrahepatic cholestasis in rats through modulation of NF-kB\/PDGF\/klf6\/PPAR\u03b3 and PI3K\/Akt pathways","author":"Alaaeldin","year":"2024","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"10","key":"10.1016\/j.taap.2025.117585_bb0030","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1007\/s00210-024-03119-2","article-title":"Vincamine alleviates intrahepatic cholestasis in rats through modulation of NF-kB\/PDGF\/klf6\/PPAR\u03b3 and PI3K\/Akt pathways","volume":"397","author":"Alaaeldin","year":"2024","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.taap.2025.117585_bb0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopha.2018.07.126","article-title":"Sitagliptin attenuates myocardial apoptosis via activating LKB-1\/AMPK\/Akt pathway and suppressing the activity of GSK-3\u03b2 and p38\u03b1\/MAPK in a rat model of diabetic cardiomyopathy","volume":"107","author":"Al-Damry","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0040","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.1038\/s41598-023-36829-3","article-title":"Sitagliptin ameliorates busulfan-induced pulmonary and testicular injury in rats through antioxidant, anti-inflammatory, antifibrotic, and antiapoptotic effects","volume":"13","author":"Ali","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.taap.2025.117585_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/diseases11040184","article-title":"Protective effects of sitagliptin on streptozotocin-induced hepatic injury in diabetic rats: a possible mechanisms","volume":"11","author":"Alqahtani","year":"2023","journal-title":"Diseases"},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41855","article-title":"Livogrit mitigates ANIT-induced cholestasis-like symptoms in an in vivo model by curbing hepatic inflammation and regulating BAX, TGF-\u03b2, MMP-9 and \u03b1-SMA gene expression","volume":"11","author":"Balkrishna","year":"2025","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0055","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000026","article-title":"Discovering NF-\u03baB","volume":"1","author":"Baltimore","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.taap.2025.117585_bb0060","first-page":"8479868","article-title":"(2021a): Paeoniflorin protects against ANIT-induced Cholestatic liver injury in rats via the activation of SIRT1-FXR signaling pathway","volume":"1","author":"Chen","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.taap.2025.117585_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2021.103672","article-title":"Intrahepatic cholestasis induced by \u03b1-naphthylisothiocyanate can cause gut-liver axis disorders","volume":"86","author":"Chen","year":"2021","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/toxsci\/kfp094","article-title":"Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice","volume":"110","author":"Cui","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.taap.2025.117585_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216301","article-title":"Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers","volume":"14","author":"El Awdan","year":"2019","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.taap.2025.117585_bb0085","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/1535370216643418","article-title":"Cardioprotective effects of sitagliptin against doxorubicin-induced cardiotoxicity in rats","volume":"241","author":"El-Agamy","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"07","key":"10.1016\/j.taap.2025.117585_bb0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/a-1842-7596","article-title":"Dipeptidyl peptidase-4 inhibitor sitagliptin exhibits antioxidant mechanism for abrogation of cyclophosphamide-induced cardiac damage and oxidative hepatorenal toxicity in rats","volume":"72","author":"Famurewa","year":"2022","journal-title":"Drug Research."},{"key":"10.1016\/j.taap.2025.117585_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121343","article-title":"Quercetin potentiates the hepatoprotective effect of sildenafil and\/or pentoxifylline against intrahepatic cholestasis: role of Nrf2\/ARE, TLR4\/NF-\u03baB, and NLRP3\/IL-1\u03b2 signaling pathways","volume":"314","author":"Fawzy","year":"2023","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis\u2014overview","volume":"254","author":"Friedman","year":"2008","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.taap.2025.117585_bb0105","doi-asserted-by":"crossref","first-page":"G1324","DOI":"10.1152\/ajpgi.90564.2008","article-title":"Interleukin-1 participates in the progression from liver injury to fibrosis","volume":"296","author":"Gieling","year":"2009","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology."},{"issue":"51","key":"10.1016\/j.taap.2025.117585_bb0110","doi-asserted-by":"crossref","first-page":"83951","DOI":"10.18632\/oncotarget.13796","article-title":"Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis","volume":"7","author":"Gong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2025.117585_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155347","article-title":"JiaGaSongTang improves chronic cholestasis via enhancing FXR-mediated bile acid metabolism","volume":"128","author":"He","year":"2024","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.taap.2025.117585_bb0120","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.3390\/cells10102618","article-title":"Bile acids activate NLRP3 inflammasome, promoting murine liver inflammation or fibrosis in a cell type-specific manner","volume":"10","author":"Holtmann","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0125","doi-asserted-by":"crossref","first-page":"2586305","DOI":"10.1155\/2022\/2586305","article-title":"Sitagliptin Alleviates Radiation-Induced Intestinal Injury by Activating NRF2-Antioxidant Axis, Mitigating NLRP3 Inf--lammasome Activation, and Reversing Gut Microbiota Disorder","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0130","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1159\/000490688","article-title":"Anti-inflammatory action of sitagliptin and linagliptin in doxorubicin nephropathy","volume":"43","author":"Jo","year":"2018","journal-title":"Kidney Blood Press. Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.21834","article-title":"Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis","volume":"31","author":"Joshi","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"5","key":"10.1016\/j.taap.2025.117585_bb0140","first-page":"L834","article-title":"DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice","volume":"315","author":"Kawasaki","year":"2018","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"13","key":"10.1016\/j.taap.2025.117585_bb0145","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21608\/mjfmct.2019.46710","article-title":"Potential protective role of Sitagliptin (Januvia) against acetaminophen-induced hepatotoxicity in adult albino rats","volume":"27","author":"Khodeary","year":"2019","journal-title":"Mansoura Journal of Forensic Medicine and Clinical Toxicology."},{"issue":"2","key":"10.1016\/j.taap.2025.117585_bb0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000438651","article-title":"TGF-\u03b2 type I receptor kinase inhibitor EW-7197 suppresses cholestatic liver fibrosis by inhibiting HIF1\u03b1-induced epithelial mesenchymal transition","volume":"38","author":"Kim","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.taap.2025.117585_bb0160","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2025.117585_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2017.07.053","article-title":"Amelioration of amyloid \u03b2-induced retinal inflammatory responses by a LXR agonist TO901317 is associated with inhibition of the NF-\u03baB signaling and NLRP3 inflammasome","volume":"360","author":"Lei","year":"2017","journal-title":"Neuroscience"},{"issue":"57","key":"10.1016\/j.taap.2025.117585_bb0170","doi-asserted-by":"crossref","first-page":"97137","DOI":"10.18632\/oncotarget.21385","article-title":"Chicken bile powder protects against \u03b1-naphthylisothiocyanate-induced cholestatic liver injury in mice","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2025.117585_bb0175","first-page":"6565283","article-title":"(2019): methane-rich saline counteracts cholestasis-induced liver damage via regulating the TLR4\/NF-\u03baB\/NLRP3 Inflammasome pathway","volume":"1","author":"Li","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0180","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1167\/iovs.12-10849","article-title":"Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration","volume":"54","author":"Liu","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.taap.2025.117585_bb0185","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.922644","article-title":"Sitagliptin inhibits extracellular matrix accumulation and proliferation in lung fibroblasts","volume":"26","author":"Liu","year":"2020","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research."},{"key":"10.1016\/j.taap.2025.117585_bb0190","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Physiol."},{"issue":"12","key":"10.1016\/j.taap.2025.117585_bb0195","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/jphp.13008","article-title":"Paeonia lactiflora pall. Regulates the NF-\u03baB-NLRP3 inflammasome pathway to alleviate cholestasis in rats","volume":"70","author":"Ma","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2025.117585_bb0200","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3748\/wjg.14.1108","article-title":"Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis","volume":"14","author":"Mas","year":"2008","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.taap.2025.117585_bb0205","series-title":"Hepatobiliary and Skeletal Muscle Enzymes and Liver Function Tests. Veterinary Laboratory Medicine: Interpretation and Diagnosis","first-page":"192","volume":"169","author":"Meyer","year":"2004"},{"issue":"2","key":"10.1016\/j.taap.2025.117585_bb0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/fcp.12736","article-title":"Sitagliptin\u2019s renoprotective effect in a diabetic nephropathy model in rats: the potential role of PI3K\/AKT pathway","volume":"36","author":"Mohamed","year":"2022","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2025.117585_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153889","article-title":"Targeting SIRT1\/AMPK\/Nrf2\/NF-\u043aB by sitagliptin protects against oxidative stress-mediated ER stress and inflammation during ANIT-induced cholestatic liver injury","volume":"507","author":"Mosaoa","year":"2024","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.taap.2025.117585_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07604","article-title":"Portulaca oleracea methanolic extract attenuate bile duct ligation-induced acute liver injury through hepatoprotective and anti-inflammatory effects","volume":"7","author":"Moslemi","year":"2021","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.taap.2025.117585_bb0225","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.taap.2025.117585_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28400","article-title":"Alleviation of taurine on liver injury of type 2 diabetic rats by improving antioxidant and anti-inflammatory capacity","volume":"10","author":"Ouyang","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.taap.2025.117585_bb0235","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000045217","article-title":"Coexpression of collagens and collagen-binding heat shock protein 47 in human diabetic nephropathy and IgA nephropathy","volume":"80","author":"Razzaque","year":"1998","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.taap.2025.117585_bb0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2025.117585_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108088","article-title":"Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation\/NF-\u03baB inhibition","volume":"100","author":"Sharawy","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2025.117585_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102404","article-title":"Inhibition of NLRP3-mediated crosstalk between hepatocytes and liver macrophages by geniposidic acid alleviates cholestatic liver inflammatory injury","volume":"55","author":"Song","year":"2022","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0255","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2025.117585_bb0260","first-page":"52438","article-title":"Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis","volume":"96","author":"Tag","year":"2015","journal-title":"Journal of Visualized Experiments: JoVE."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0265","first-page":"3837","article-title":"The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats","volume":"17","author":"Tang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.taap.2025.117585_bb0270","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3390\/antiox10081168","article-title":"Sitagliptin modulates oxidative, nitrative and halogenative stress and inflammatory response in rat model of hepatic ischemia-reperfusion","volume":"10","author":"Trocha","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.taap.2025.117585_bb0275","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11418-018-01275-3","article-title":"Andrographolide impairs alpha-naphthylisothiocyanate-induced cholestatic liver injury in vivo","volume":"73","author":"Wang","year":"2019","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.taap.2025.117585_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112672","article-title":"Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses","volume":"254","author":"Wang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0285","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41420-021-00625-7","article-title":"Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NF\u03baB pathway","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2025.117585_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111133","article-title":"Inflammation: cause or consequence of chronic cholestatic liver injury","volume":"137","author":"Woolbright","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bb0295","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0300","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000484908","article-title":"Effect of Huagantongluofang, a Chinese traditional medicine, in hepatic fibrogenesis in a mouse model of biliary cirrhosis","volume":"44","author":"Xuan","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.taap.2025.117585_bb0305","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.etp.2004.04.008","article-title":"Effects of lipopolysaccharide on the appearance of macrophage populations and fibrogenesis in cisplatin-induced rat renal injury","volume":"56","author":"Yamate","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0310","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1038\/s41598-017-04536-5","article-title":"Herbal medicine Yinchenhaotang protects against \u03b1-naphthylisothiocyanate-induced cholestasis in rats","volume":"7","author":"Yan","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.taap.2025.117585_bb0315","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/jps.23584","article-title":"An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters","volume":"102","author":"Yang","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2025.117585_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116833","article-title":"Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor","volume":"318","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117585_bb0325","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1038\/s41598-017-10524-6","article-title":"PPAR\u03b1 activation protects against cholestatic liver injury","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.taap.2025.117585_bb0330","article-title":"Regulation of NLRPs by reactive oxygen species: a story of crosstalk. Biochimica et Biophysica Acta (BBA)-molecular","volume":"1871","author":"Ziehr","year":"2024","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.taap.2025.117585_bib331","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11596-022-2573-9","article-title":"Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice","volume":"42","author":"Zhou","year":"2022","journal-title":"Curr. Med. Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:08:36Z","timestamp":1780722516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25003618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"alternative-id":["S0041008X25003618"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117585","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of NF-\u043aB\/NLRP3 signaling by sitagliptin attenuates cholestatic hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117585"}}